S&P 500 Futures
(0.25%) 5 535.25 points
Dow Jones Futures
(0.20%) 39 548 points
Nasdaq Futures
(0.27%) 19 981 points
Oil
(0.63%) $82.05
Gas
(-1.96%) $2.55
Gold
(0.19%) $2 344.00
Silver
(0.25%) $29.64
Platinum
(-0.56%) $996.30
USD/EUR
(-0.23%) $0.931
USD/NOK
(-0.18%) $10.66
USD/GBP
(-0.09%) $0.790
USD/RUB
(1.98%) $87.43

Realtime updates for Perspective Therapeutics, [CATX]

Exchange: NYSE Sector: Healthcare Industry: Medical - Devices
Last Updated28 Jun 2024 @ 16:00

1.01% $ 9.97

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -1.24% compare to its pairs and should correct downwards.

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally...

Stats
Today's Volume 7.95M
Average Volume 749 104
Market Cap 672.28M
EPS $-0.0369 ( Q1 | 2023-09-30 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.86
(Sector) 49.64
(Industry) 37.79
ATR14 $0.0480 (0.49%)
ABT -0.71%
ALUR -23.26%
AORT 3.22%
AVNS 1.63%
BFLY -3.33%
BFLY-WT 4.91%
BIO 0.41%
BIO-B 0.00%
BSX 0.01%
BSX-PA 2.37%
CATX 1.01%
CNMD 2.70%
CRY 1.42%
EW -1.04%
FNA 2.86%
GKOS 0.83%
GMED -0.52%
INSP -1.11%
ITGR 1.10%
MDT 0.10%
NVRO 0.72%
OWLT 6.46%
PEN 2.90%
PHG -1.87%
RBOT -15.78%
SNN 0.12%
SONX 0.00%
STE 1.43%
SYK 0.15%
VAPO -1.87%
ZBH 0.14%
Insider Trading
Date Person Action Amount type
2024-06-20 Williamson Robert F Iii Buy 23 000 Stock option (right to buy)
2024-06-20 Morich Frank Buy 23 000 Stock option (right to buy)
2024-06-20 Woods Lori A Buy 23 000 Stock option (right to buy)
2024-06-20 Henson Heidi Buy 23 000 Stock option (right to buy)
2024-06-20 Spoor Johan M. Buy 500 000 Stock option (right to buy)
INSIDER POWER
99.90
Last 36 transactions
Buy: 62 148 790 | Sell: 30 000
Correlation (AI algo v.1.1b): Overvalued: -1.24% $9.98 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.33 (neutral)
Short: 0.02 (neutral)
Signal:(51.936) Neutral

Perspective Therapeutics, Correlation

10 Most Positive Correlations
KLG0.836
GAQ0.823
ECCC0.819
SBXC0.819
10 Most Negative Correlations
AIU-0.865
CCG-0.832
BBAI-WT-0.828
QBTS-0.82
GETR-0.807
RTO-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Perspective Therapeutics, Correlation - Currency/Commodity

The country flag 0.15
( neutral )
The country flag 0.11
( neutral )
The country flag 0.00
( neutral )
The country flag -0.35
( neutral )
The country flag 0.00
( neutral )
The country flag -0.31
( neutral )

Perspective Therapeutics, Financials

Annual 2022
Revenue: $7.10M
Gross Profit: $1.63M (23.00 %)
EPS: $-0.100
FY 2022
Revenue: $7.10M
Gross Profit: $1.63M (23.00 %)
EPS: $-0.100
FY 2022
Revenue: $10.80M
Gross Profit: $4.62M (42.76 %)
EPS: $-0.0504

Financial Reports:

No articles found.

Perspective Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Perspective Therapeutics,

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.6075489521027 seconds
Number of API calls: 3
Number of DB calls: 9